Pfizer CEO Albert Bourla suffering from minor symptoms after testing positive for COVID-19
Albert Bourla, CEO of Pfizer, said on Monday that he had tested positive for COVID-19 and was suffering from minor symptoms.
Bourla, 60, said that he had begun a course of Paxlovid, the oral antiviral therapy for COVID-19 produced by the company, and that he was isolating himself and taking all necessary protocols to protect public health.
“I am confident that I will have a speedy recovery,” Bourla stated.
Several prominent individuals, including President Joe Biden and his chief medical adviser, Dr. Anthony Fauci, have tested positive for the infectious disease in the past several months.
After two episodes with COVID-19, Biden was isolated in the White House for almost two weeks. The second incidence is thought to be a phenomenon known as a “rebound,” which is experienced by certain COVID patients when they are taking Paxlovid.
Antiviral medicine Paxlovid is used to treat high-risk individuals, such as the elderly.
Four doses of the COVID vaccine produced by Pfizer and its German partner BioNTech have been administered to Bourla.
